免疫检查点抑制剂诱发糖尿病发病前后胰岛素分泌能力的纵向观察：两例报告
Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases.
作者信息
Fujiwara Noriko, Watanabe Mayu, Katayama Akihiro, Noda Yohei, Eguchi Jun, Kataoka Hitomi, Kagawa Shunsuke, Wada Jun
机构信息
Department of Nephrology, Rheumatology, Endocrinology and Metabolism Dentistry and Pharmaceutical Sciences Okayama University Graduate School of Medicine Okayama Japan.
Division of Endocrinology and Metabolism Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital Hiroshima Japan.
出版信息
Clin Case Rep. 2021 Sep 7;9(9):e04574. doi: 10.1002/ccr3.4574. eCollection 2021 Sep.
Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.
免疫检查点抑制剂诱导的糖尿病是一种罕见的免疫相关不良事件。本报告阐述了免疫检查点抑制剂诱导的糖尿病发病前后的临床数据及胰岛素分泌能力。
Zotero 插件